HER2 in Gastric Cancer: An Immunohistochemical Study on Tissue Microarrays and the Coressponding Whole-Tissue Sections with a Supplemental Fish Study

被引:11
|
作者
Gasljevic, Gorana [1 ]
Lamovec, Janez [1 ]
Contreras, Juan Antonio [1 ]
Zadnik, Vesna [2 ]
Blas, Mateja [1 ]
Gasparov, Slavko [3 ,4 ]
机构
[1] Inst Oncol, Dept Pathol, Ljubljana 1000, Slovenia
[2] Inst Oncol, Canc Registry, Ljubljana 1000, Slovenia
[3] Univ Hosp Merkur, Dept Pathol, Zagreb 10000, Croatia
[4] Univ Zagreb, Sch Med, Zagreb 10000, Croatia
关键词
FISH; Gastric carcinoma; HER2; Immunohistochemistry; TMA; Whole sections; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; PROGNOSTIC-FACTOR; CARCINOMA; EXPRESSION; ASSOCIATION; VALIDATION; SURVIVAL; RECEPTOR;
D O I
10.1007/s12253-013-9654-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since focal HER2 expression is an issue in GC, TMA construction from the paraffin-embedded surgically-obtained tissue may not reflect its real status. The aim of this study was to assess the HER2 status in tissue microarrays (TMAs) and the corresponding whole sections using HercepTest immunohistochemistry (IHC), and to correlate it and to assess the concordance of HER2 IHC and fluorescence in situ hybridization (FISH) in TMAs. Concordance of the HER2 expression status for 302 cases of gastric cancer using 9 paired TMAs was evaluated using a 2-mm core size and 305 corresponding whole sections. Concordance of the IHC and FISH HER2 status was compared. In addition,, the HER2 status was compared to clinicopathological characteristics and patients' survival. Using the whole-section approach, HER2 over-expression was found in 25.2 % (HER2 3+ 6.6 %, HER2 2+ 18.7 %) of tumours. The overall concordance of IHC between the cores and the whole section was 84.9 %; 15.1 % of the tumours showed HER2 amplification. The overall concordance of IHC and FISH on cores was 75.7 %. The level of amplification correlated with the IHC score. Relationship between the intestinal and papillary types and tumour grade was observed for tumours with over-expression and amplification, whereas tumour location was related only to over-expression. There was a statistically significant difference in the overall survival of the patients, which was related to HER2 amplification. In conclusion, good concordance of the IHC HER2 results between tissue cores in TMA and whole sections, and excellent concordance of the IHC and FISH results on tissue cores was found. At least a part of the observed IHC HER2 heterogeneity could very likely be explained by fixation artifacts. With adequate fixation, a higher concordance of IHC HER2 between the cores and the whole sections can be expected. The TMA approach could enable an easier analysis of more than one representative tumour block.
引用
收藏
页码:855 / 865
页数:11
相关论文
共 50 条
  • [41] Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays
    Bi, J.
    Guo, A. L.
    Lai, Y. R.
    Li, B.
    Zhong, J. M.
    Wu, H. Q.
    Xie, Z.
    He, Y. L.
    Lv, Z. L.
    Lau, S. H.
    Wang, Q.
    Huang, X. H.
    Zhang, L. J.
    Wen, J. M.
    Guan, X. Y.
    NEOPLASMA, 2010, 57 (03) : 191 - 197
  • [42] Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
    Xiu Li Zhang
    Yun Sheng Yang
    Dong Ping Xu
    Jian Hui Qu
    Ming Zhou Guo
    Yan Gong
    Jin Huang
    World Journal of Surgery, 2009, 33 : 2112 - 2118
  • [43] Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
    Zhang, Xiu Li
    Yang, Yun Sheng
    Xu, Dong Ping
    Qu, Jian Hui
    Guo, Ming Zhou
    Gong, Yan
    Huang, Jin
    WORLD JOURNAL OF SURGERY, 2009, 33 (10) : 2112 - 2118
  • [44] A study of HER2 gene amplification and protein expression in gastric cancer
    Yan, Benedict
    Yau, Ee Xuan
    Omar, Siti Shyba Bte
    Ong, Chee Wee
    Pang, Brendan
    Yeoh, Khay Guan
    Salto-Tellez, Manuel
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (09) : 839 - 842
  • [46] Trainable Immunohistochemical HER2/neu Image Analysis A Multisite Performance Study Using 260 Breast Tissue Specimens
    Nassar, Aziza
    Cohen, Cynthia
    Agersborg, Sally S.
    Zhou, Weidong
    Lynch, Kathleen A.
    Albitar, Maher
    Barker, Edward A.
    Vanderbilt, Burton L.
    Thompson, Jim
    Heyman, Eugene R.
    Lange, Holger
    Olson, Allen
    Siddiqui, Momin T.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (07) : 896 - 902
  • [47] Epidemiologic study on HER2 (+) early/advanced stage gastric cancer: An evaluation on HER2 positivity in gastric and gastroesophageal junction cancers
    Erdamar, S.
    Kepil, N.
    Dursun, A.
    Ekinci, O.
    Sagol, O.
    Sarioglu, S.
    Doganavsargil, B.
    Sezak, M.
    Ozdener, F.
    Ustundag, K.
    VIRCHOWS ARCHIV, 2014, 465 : S148 - S148
  • [48] HER2 Status in Gastric Cancer: Correlation between IHC and FISH
    Tafe, L. J.
    Zaidinski, M.
    Hedvat, C.
    Tang, L.
    Janjigian, Y.
    Shah, M.
    Barbashina, V.
    LABORATORY INVESTIGATION, 2010, 90 : 170A - 170A
  • [49] HER2 Status in Gastric Cancer: Correlation between IHC and FISH
    Tafe, L. J.
    Zaidinski, M.
    Hedvat, C.
    Tang, L.
    Janjigian, Y.
    Shah, M.
    Barbashina, V.
    MODERN PATHOLOGY, 2010, 23 : 170A - 170A
  • [50] Tissue microarray technology in breast cancer HER2 diagnostics
    Egervari, Kristof
    Szollosi, Zoltan
    Nemes, Zoltan
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (03) : 169 - 177